132 related articles for article (PubMed ID: 7984269)
1. The ontogeny of tolerance to the 5-HT1A agonist 8-OH-DPAT: a study in the rat.
Johansson-Wallsten CE; Meyerson BJ
Neuropharmacology; 1994; 33(3-4):325-30. PubMed ID: 7984269
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Yu H; Lewander T
Eur Neuropsychopharmacol; 1997 Aug; 7(3):165-72. PubMed ID: 9213074
[TBL] [Abstract][Full Text] [Related]
3. Counteraction of the rapid tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia in rats by activation of the GABAA receptor-chloride channel complex.
Kelder D; Ross SB
Pharmacol Toxicol; 2002 Jan; 90(1):14-9. PubMed ID: 12005107
[TBL] [Abstract][Full Text] [Related]
4. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
Yu H; Liu Y; Hacksell U; Lewander T
J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats.
Zuideveld KP; Treijtel N; Van der Graaf PH; Danhof M
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):67-73. PubMed ID: 10778927
[TBL] [Abstract][Full Text] [Related]
6. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.
Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD
J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758
[TBL] [Abstract][Full Text] [Related]
8. TJS-010, a new prescription of oriental medicine, enhances 8-OH-DPAT-induced effects in rats.
Kagaya A; Tanra AJ; Shinno H; Kugaya A; Muraoka M; Oyamada T; Uchitomi Y; Yamawaki S
J Neural Transm (Vienna); 1996; 103(1-2):69-75. PubMed ID: 9026378
[TBL] [Abstract][Full Text] [Related]
9. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
Prinssen EP; Koek W; Colpaert FC; Kleven MS
Behav Pharmacol; 2000 Jun; 11(3-4):299-305. PubMed ID: 11103884
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity to 8-hydroxy-2-(di-n-propylamino)tetralin-induced corticosterone secretion and hypothermia between Sprague-Dawley rats from different breeding colonies.
Kelder D; Ross SB
Pharmacol Toxicol; 2001 Dec; 89(6):295-300. PubMed ID: 11903954
[TBL] [Abstract][Full Text] [Related]
11. A single pretreatment with 8-OH-DPAT reduces behavioral indices of serotonin 1A receptor activation in ovariectomized rats.
Maswood N; Uphouse L
Neuropharmacology; 1997; 36(11-12):1725-32. PubMed ID: 9517444
[TBL] [Abstract][Full Text] [Related]
12. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
[TBL] [Abstract][Full Text] [Related]
15. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
16. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
Johansson-Wallsten CE; Berg M; Meyerson BJ
Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT1A agonist 8-OH-DPAT increases attachment maintenance but decreases suckling-related intake in 17-18-day-old rat pups.
Spear LP; Frambes NA; Goodwin GA; Moody CA
Pharmacol Biochem Behav; 1994 Jan; 47(1):133-9. PubMed ID: 8115414
[TBL] [Abstract][Full Text] [Related]
19. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
Eltayb A; Lindblom S; Oerther S; Ahlenius S
Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
[TBL] [Abstract][Full Text] [Related]
20. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence.
Kleven M; Ybema C; Carilla E; Hamon M; Koek W
Eur J Pharmacol; 1995 Aug; 281(3):219-28. PubMed ID: 8521904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
